Brief memory and executive test: Evaluation of a new screening test for cognitive impairment due to small vessel disease

Age and Ageing

Volumn 41, Issue 2, 2012, Pages 212-218

  Brookes, Rebecca L ^a   Hannesdottir, Kristin ^a   Lawrence, Robert ^a   Morris, Robin G ^b   Markus, Hugh S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Elderly; Lacunar; Rapid screening; Small vessel disease; Stroke; Vascular cognitive impairment

Indexed keywords

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRIEF MEMORY AND EXECUTIVE TEST; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EVALUATION RESEARCH; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; ORIENTATION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CEREBRAL SMALL VESSEL DISEASES; COGNITION; COGNITION DISORDERS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; EXECUTIVE FUNCTION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LONDON; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84857202363     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afr172     Document Type: Article

References (21)

1. Erkinjuntti T, Kurz A, Small GW, Bullock R, Lilienfeld S, Damaraju CV. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. Clin Ther 2003; 25: 1765-82.
2. Erkinjuntti T, Gauthier S. The concept of vascular cognitive impairment. Front Neurol Neurosci 2009; 24: 79-85.
3. O'Brien JT, Erkinjuntti T, Reisberg B et al. Vascular cognitive impairment. Lancet Neurol 2003; 2: 89-98.
4. O'Sullivan M, Morris RG, Markus HS. Brief cognitive assessment for patients with cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2005; 76: 1140-5.
5. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 1356-64.
6. Dichgans M, Markus HS, Salloway S et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008; 7: 310-8.
7. Hachinski V, Iadecola C, Petersen RC et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-41.
8. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
9. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922-35.
10. Ihl R, Frolich L, Dierks T, Martin EM, Maurer K. Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res 1992; 44: 93-106.
11. Nasreddine ZS, Phillips NA, Bedirian V et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-9.
12. Dong Y, Sharma VK, Chan BP et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci 2010; 299: 15-8.
13. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination (versus) the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010; 41: 1290-3.
14. Roth M, Huppert F, Mountjou CQ, Tym E. CAMDEX-R: The Cambridge Examination for Mental Disorders of the Elderly. Cambridge University Press, Cambridge, UK, 1998. Ref Type: Generic.
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders. 4th edition. 1-1-1994. Washington: APA, 1994. Ref Type: Generic.
17. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-4.
18. O'Bryant SE, Humphreys JD, Smith GE et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol 2008; 65: 963-7.
19. Folstein MF, Folstein SE, White T, Messer MA. Mini-Mental State Examination, 2nd edition. Florida: PAR, 2010. Ref Type: Generic.
20. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. J Am Med Assoc 1997; 277: 813-7.
21. Charlton RA, Morris RG, Nitkunan A, Markus HS. The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology 2006; 66: 1523-6.